BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24758228)

  • 21. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL; Huang HQ; Lin XB; Xia ZJ; Li YH; Wang W; He YJ; Pan ZH; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):943-6. PubMed ID: 15301720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis.
    Yu AP; Yang H; Wu EQ; Setyawan J; Mocarski M; Blum S
    J Med Econ; 2011; 14(3):315-23. PubMed ID: 21500975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
    d'Amore F; Radford J; Relander T; Jerkeman M; Tilly H; Osterborg A; Morschhauser F; Gramatzki M; Dreyling M; Bang B; Hagberg H
    Br J Haematol; 2010 Sep; 150(5):565-73. PubMed ID: 20629661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
    Mehra M; Hill K; Nicholl D; Schadrack J
    J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population.
    AbuDagga A; Sun SX; Tan H; Solem CT
    J Med Econ; 2013; 16(3):421-9. PubMed ID: 23336296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
    Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
    Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost effectiveness and budget impact of natalizumab in patients with relapsing multiple sclerosis.
    Chiao E; Meyer K
    Curr Med Res Opin; 2009 Jun; 25(6):1445-54. PubMed ID: 19422279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of adverse events in patients with metastatic renal cell carcinoma.
    Hagiwara M; Borker R; Oster G
    Clin Ther; 2013 Dec; 35(12):1955-1963.e2. PubMed ID: 24290735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
    Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
    Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database.
    Vekeman F; McKenzie RS; Bookhart BK; Laliberté F; Duh MS; Tak Piech C; Lefebvre P
    J Med Econ; 2009 Mar; 12(1):1-8. PubMed ID: 19450059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom.
    Rule S; Collins GP; Samanta K
    J Med Econ; 2014 Jul; 17(7):459-68. PubMed ID: 24720836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of illness and treatment patterns among patients with peripheral T-cell lymphoma in the US healthcare setting.
    Petrilla AA; Shah A; Feliciano J; Woolery J; LeBlanc TW
    Curr Med Res Opin; 2021 Jul; 37(7):1189-1197. PubMed ID: 33944646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost differential by site of service for cancer patients receiving chemotherapy.
    Hayes J; Hoverman RJ; Brow ME; Dilbeck DC; Verrilli DK; Garey J; Espirito JL; Cardona J; Beveridge R
    Am J Manag Care; 2015 Mar; 21(3):e189-96. PubMed ID: 26014306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial.
    Park S; Kim AY; Cho H; Baik D; Lee H; Cho S; Kang HY
    BMC Cancer; 2020 Nov; 20(1):1157. PubMed ID: 33243162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population.
    Duh MS; Hackshaw MD; Ivanova JI; Kruse G; Miller LA; Lefebvre P; Karner P; Wong B
    Sarcoma; 2013; 2013():947413. PubMed ID: 24453570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National estimates of price variation by site of care.
    Higgins A; Veselovskiy G; Schinkel J
    Am J Manag Care; 2016 Mar; 22(3):e116-21. PubMed ID: 26978238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exploratory analysis of healthcare costs and utilization of pediatric patients with Crohn's disease.
    Waters HC; Hilliard RP; Teng E; Rahman MI; Ferrer R; Pulicharam J; Nejadnik B
    Dig Dis Sci; 2009 Dec; 54(12):2650-4. PubMed ID: 19130225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.